Pomolic Acid from the Dong Botanical Drug Madeng’ai Suppresses TNF-α-Induced Inflammatory Response in RA-HFLS by Inhibiting NF-κB Signaling Pathway Activation
Sisi Huang, Wei Cai, Yan Wang, Xiaoliang Xing, Zaiqi Zhang · 2026
Read Pomolic Acid from the Dong Botanical Drug Madeng’ai Suppresses TNF-α-Induced Inflammatory Response in RA-HFLS by Inhibiting NF-κB Signaling Pathway Activation by Sisi Huang, Wei Cai, Yan Wang, Xiaoliang Xing, Zaiqi Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13209270.txt.
Description
Sisi Huang, Wei Cai, Yan Wang, Xiaoliang Xing, and Zaiqi Zhang test a plant compound against joint inflammation in 2026. The compound comes from a traditional Dong medicine herb. A cell model of rheumatoid arthritis, driven by an inflammatory signal, served as the test bed.
Content of the compound varied by region and harvest year in the herb samples. Network and docking studies pointed to a central inflammatory pathway as the likely target. Safety and drug-likeness forecasts looked acceptable. Cell tests then measured survival and inflammatory output under treatment, with pathway activity checked by protein and gene assays.
Catalog record
| CREATOR | Sisi Huang, Wei Cai, Yan Wang, Xiaoliang Xing, Zaiqi Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |